Warning for UK CBD industry as regulator sets approval deadline
Products containing cannabis extract cannabidiol (CBD) are set to be “taken off the shelves” next year if they fail to gain regulatory approval.
The Food Standards Agency (FSA) has announced that products must be officially registered by March 2021 to avoid being withdrawn.
The CBD industry has grown in the UK over the past several years, with consumers using CBD oils, snacks and and drinks for a range of medicinal purposes, including pain relief and to combat insomnia.
Despite the growing popularity of the non-psychoactive substance, no products in the UK have yet been approved by FSA standards.
The agency has also issued new advice on the use of CBD, including information on interactions with medication.
FSA boss Emily Miles explained: “The CBD industry must provide more information about the safety and contents of these products to the regulator by March 2021, or the products will be taken off the shelves.”
Want your business, product or service to be seen regionally and nationally? Bdaily helps you get your story in front of the right audience, every day. Find out how Bdaily can help →
Join more than 55,000 subscribers by signing up to our daily bulletin each morning here.
Enjoy the read? Get Bdaily delivered.
Sign up to receive our popular morning National email for free.
The true value of HR in an AI-driven working world
What new business rates guidance means for pubs
Business success starts with people investment
It's time to confront the digital poverty crisis
Why a business exit is no longer all or nothing
Culture is the foundation for sustainable growth
Business must help young people take root in work
Purposeful procurement for long-term growth
Time to rethink outdated views on apprenticeships
The scale-ups rocketing through our fast world
Care about the experience, not just the outcome
The rise of an alternative investor model